The Amelia Platform
Amelia is an IP protected patent-pending medical device that can operate in thousands of healthcare locations, even those with limited resources.
Amelia enables hundreds of complex clinical blood tests to be entirely self-administered by patients
Tests take about 30 minutes
Production costs are competitive with existing point-of-care solutions
No oversight is required by a healthcare professional. Simply access a kiosk at your doctor’s office or clinic.
Test results are immediately available to patients and healthcare providers
Amelia utilizes a novel electrochemical and microfluidic approach to testing. This cutting-edge science is validated by 100 peer-reviewed research articles.
Amelia’s novel testing approach allows for automation and low sample volumes
1st clinical application of electrochemical microfluidic detection in blood diagnostics
Applies the latest approaches to transdermal microneedle blood collection — validated from existing FDA cleared devices